Kerwyn Casey Huang (Stanford / CZ Biohub) has 389 indexed works with ~20,893 citations and an h-index of 73, with sustained output from 2003 through 2026 and citation peaks in 2017 (~2,667/year) and 2020 (~2,783/year) per OpenAlex metadata. His citation trajectory reflects both foundational bacterial cell-biology work and later dominance in microbiome science.
Across six recent papers, extracted quality scores cluster at 9/10 for scientific quality, novelty, usefulness, and explanatory depth β unusually uniform for a productive senior lab.
Microbiome ecology/evolution: His group's 2019 Cell Host & Microbe study showed post-antibiotic recovery depends on diet, community context, and environmental reservoirs , extended in 2026 with 2,876 daily fecal samples across 87 mice using shotgun metagenomics (~45B reads), MIDAS2 strain tracking, and phage profiling to demonstrate path-dependent recovery via SNV sweeps (gyrA S83F, S12 K42R), host-to-host transmission, and prophage activity . Falsification criteria are explicitly defined β a strength few labs match.
Phage-based community editing: A 2026 preprint used a four-phage cocktail (MOI β100) to knock out Escherichia fergusonii across four stool-derived communities, mechanistically resolving reversible inverton-mediated resistance and demonstrating Ef's necessity for Salmonella colonization resistance (~100-fold STm increase in ΞEf communities); a 1,025,611-mutant transposon library identified outer-membrane genes (bamB, bamE, skp, ompC, envZ, rseB, lpp) as community fitness determinants .
Bacterial cell mechanics and physiology: The lab demonstrated the outer membrane as a load-bearing element (666 citations) and, in 2025, that the cytoplasmic membrane bears load via MreB-coupled peptidoglycan linkages, with rigorous single-cell sample sizes (n=11β348 per condition) . Complementary mBio work showed Rcs envelope-stress activation shortens cells by upregulating FtsZ, with context-dependence revealed by A22 co-treatment controls .
AI-driven discovery: Eubiota (2026) is a modular agentic AI framework that reached 87.7% benchmark accuracy vs 67.2% baseline, validated nitrosative-stress genes (uvrA, ruvA) enriched across ~140,000 IBD genomes, designed in vivo-validated consortia, and was preferred by 70.6% of 15 domain experts over GPT-5.1 .
Strengths: mechanistic depth, quantitative rigor, open data/code deposition (Bitbucket, SRA, Zenodo, Stanford Digital Repository), explicit falsification criteria, and breadth from single-molecule theory to translational microbiome AI. Weaknesses: heavy reliance on mouse/gnotobiotic and in vitro models with acknowledged limited human translation; two-donor, two-antibiotic scope in key recovery studies; Eubiota validation used small in vivo groups (n=3β5) and curated-database benchmarks vulnerable to overfitting; extraction scores were uniform (9/10) across papers, which may reflect extraction bias rather than independent assessment. The 2010 kinesin modeling paper is an early theoretical side project, lower in rigor and reproducibility. Confidence: high on bibliometrics and extracted paper content; medium on generalization beyond supplied records.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.